Home / Health / Beyond Weight Loss: GLP-1 Drugs May Slow Aging
Beyond Weight Loss: GLP-1 Drugs May Slow Aging
27 Oct
Summary
- Mouse study shows semaglutide reduced aging markers, extending lifespan.
- GLP-1s may support brain health and reduce inflammation.
- Human research is ongoing to confirm if GLP-1s slow biological aging.
GLP-1 medications are being explored for their potential to reduce biological age, a measure of how old the body functions rather than its chronological age. A lower biological age is linked to reduced mortality risk and delayed onset of age-related diseases.
Evidence from a recent mouse study suggests semaglutide, a GLP-1 drug, extended lifespan by about 12% in older female mice. Strikingly, the study also noted a restoration of neural stem cells and new brain-cell growth.
However, experts caution that human trials have not yet confirmed these effects. While GLP-1s show promise for various health conditions, including potential benefits for brain health and inflammation, their impact on slowing aging in humans remains a hypothesis.
Researchers are also examining potential side effects, such as changes in heart rate and variability. Despite these considerations, the drugs' established cardiovascular benefits and observed reduction in inflammation suggest a future possibility for GLP-1s to be marketed as longevity drugs.
